Diagnosis - Spotting the Fire
Based on clinical criteria; lab tests are supportive, not diagnostic.
📌 Mnemonic: CRASH & Burn
- Fever > 5 days ("Burn") PLUS ≥ 4 of the following:
- Conjunctivitis: Bilateral, non-purulent.
- Rash: Polymorphous, generalized.
- Adenopathy: Cervical, unilateral, >1.5 cm.
- Strawberry tongue & lip changes (redness, fissures).
- Hand & foot changes: Erythema, edema (acute); periungual desquamation (subacute).

⭐ Atypical/Incomplete KD: Suspect in infants with prolonged unexplained fever, even with <4 criteria. Echocardiography is crucial for diagnosis and assessing coronary artery involvement.
Initial Workup - The Lab Clues
- Acute Phase Reactants:
- ↑ ESR (often >100 mm/hr)
- ↑ CRP (>3 mg/dL)
- Complete Blood Count (CBC):
- Leukocytosis (>15,000/μL) with neutrophilia.
- Normocytic, normochromic anemia.
- Platelets: Normal or ↓ initially, then marked thrombocytosis from week 2.
- Other Key Labs:
- ↑ Transaminases (ALT)
- ↓ Albumin (<3 g/dL)
- Sterile pyuria
- CSF: Aseptic meningitis (pleocytosis)
⭐ Thrombocytosis is the most striking feature, typically appearing in the 2nd week. Platelet counts can rise to > 10 lakh/mm³.

First-Line Tx - Dousing the Flames
-
Goal: Rapidly control inflammation to prevent coronary artery aneurysms (CAA).
-
Administer within 10 days of fever onset for maximal efficacy.
-
Dual Therapy:
- Intravenous Immunoglobulin (IVIG):
- The cornerstone of treatment.
- Single large dose of 2 g/kg infused over 10-12 hours.
- Aspirin (ASA):
- Initially high-dose for anti-inflammatory effect: 80-100 mg/kg/day.
- After patient is afebrile for 48-72 hours, reduce to a low anti-platelet dose: 3-5 mg/kg/day.
- Intravenous Immunoglobulin (IVIG):
⭐ Treatment with IVIG within the first 10 days of illness reduces the incidence of coronary artery aneurysms from 25% to less than 5%.
- Management of Persistent Fever:
Refractory KD - Stubborn Embers
Defined as persistent or recrudescent fever ≥ 36-48h after completing initial IVIG infusion. Occurs in 10-20% of patients, carrying a higher risk of coronary artery aneurysms (CAA).

Management Algorithm:
⭐ Infliximab is often preferred in patients with high-risk lab markers (e.g., ↑CRP, ↑Ferritin) or early signs of CAA, as it may reduce coronary artery inflammation more rapidly than corticosteroids.
High‑Yield Points - ⚡ Biggest Takeaways
- IVIg (2 g/kg single dose) is the cornerstone of acute management, best given within 10 days of fever onset.
- Initial treatment includes high-dose aspirin (80-100 mg/kg/day) to rapidly control systemic inflammation.
- Aspirin is switched to a low, antiplatelet dose (3-5 mg/kg/day) once afebrile for 48-72 hours.
- The primary goal is preventing coronary artery aneurysms, the most feared complication.
- Baseline echocardiography is mandatory to assess for early cardiac changes.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app